Harrow Health Inc (HROW) - Total Assets
Based on the latest financial reports, Harrow Health Inc (HROW) holds total assets worth $416.82 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Harrow Health Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Harrow Health Inc - Total Assets Trend (2005–2025)
This chart illustrates how Harrow Health Inc's total assets have evolved over time, based on quarterly financial data. See Harrow Health Inc stock quote for real-time trading data and today's change.
Harrow Health Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Harrow Health Inc's total assets of $416.82 Million consist of 53.0% current assets and 47.0% non-current assets. Explore HROW current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 18.3% |
| Accounts Receivable | $110.89 Million | 27.8% |
| Inventory | $13.52 Million | 3.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $175.17 Million | 43.9% |
| Goodwill | $332.00K | 0.1% |
Asset Composition Trend (2005–2025)
This chart illustrates how Harrow Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Harrow Health Inc's current assets represent 53.0% of total assets in 2025, a decrease from 100.0% in 2005.
- Cash Position: Cash and equivalents constituted 18.3% of total assets in 2025, down from 100.0% in 2005.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 43.0% of total assets, an increase from 0.0% in 2005.
- Asset Diversification: The largest asset category is intangible assets at 43.9% of total assets.
Harrow Health Inc Competitors by Total Assets
Key competitors of Harrow Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317
|
China | CN¥5.17 Billion |
|
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
|
China | CN¥35.27 Billion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.89 Billion |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538
|
China | CN¥4.73 Billion |
|
Zhejiang Garden Bio-chemical High-tech Co Ltd
SHE:300401
|
China | CN¥5.91 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
|
Yabao Pharmaceutical Group Co Ltd
SHG:600351
|
China | CN¥3.34 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Harrow Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.24 | 0.62 | 8.70 |
| Quick Ratio | 2.08 | 0.58 | 8.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $127.14 Million | $-93.99 Million | $80.65 Million |
Harrow Health Inc - Advanced Valuation Insights
This section examines the relationship between Harrow Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 93.35 |
| Latest Market Cap to Assets Ratio | 2.76 |
| Asset Growth Rate (YoY) | 2.7% |
| Total Assets | $399.48 Million |
| Market Capitalization | $1.10 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Harrow Health Inc's assets at a significant premium (2.76x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Harrow Health Inc's assets grew by 2.7% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Harrow Health Inc (2005–2025)
The table below shows the annual total assets of Harrow Health Inc from 2005 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $399.48 Million | +2.70% |
| 2024-12-31 | $388.97 Million | +24.77% |
| 2023-12-31 | $311.75 Million | +98.54% |
| 2022-12-31 | $157.02 Million | +59.69% |
| 2021-12-31 | $98.33 Million | +71.08% |
| 2020-12-31 | $57.47 Million | -2.73% |
| 2019-12-31 | $59.09 Million | +19.48% |
| 2018-12-31 | $49.45 Million | +106.76% |
| 2017-12-31 | $23.92 Million | -12.22% |
| 2016-12-31 | $27.25 Million | +92.82% |
| 2015-12-31 | $14.13 Million | +37.97% |
| 2014-12-31 | $10.24 Million | -35.02% |
| 2013-12-31 | $15.76 Million | +47.22% |
| 2012-12-31 | $10.71 Million | +6551.46% |
| 2011-12-31 | $160.96K | -54.31% |
| 2010-12-31 | $352.29K | -78.93% |
| 2009-12-31 | $1.67 Million | -68.66% |
| 2008-12-31 | $5.34 Million | +25.82% |
| 2007-12-31 | $4.24 Million | +16706.92% |
| 2006-12-31 | $25.23K | -36.83% |
| 2005-12-31 | $39.94K | -- |
About Harrow Health Inc
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, in… Read more